| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2016-09-30 23:02:47 UTC |
|---|
| Update Date | 2020-04-22 15:11:43 UTC |
|---|
| BMDB ID | BMDB0003116 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Stanozolol |
|---|
| Description | Stanozolol, also known as androstanazole or stromba, belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton. Based on a literature review a significant number of articles have been published on Stanozolol. |
|---|
| Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| Androstanazole | ChEBI | | Estanozolol | ChEBI | | Stanozololum | ChEBI | | Stromba | ChEBI | | Strombaject | ChEBI | | Winstrol | ChEBI | | (5a,17b)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol | HMDB | | 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-Trimethyl-cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol | HMDB | | 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol | HMDB | | 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol | HMDB | | 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole | HMDB | | 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole | HMDB | | 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole | HMDB | | 2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8ci) | HMDB | | Anabol | HMDB | | Androstanazol | HMDB, MeSH | | Androstanazolestanazol | HMDB | | Cyclopenta[7,8]phenanthro[2,3-c]pyrazole, 2'H-androst-2-eno[3,2-c]pyrazol-17-ol deriv. | HMDB | | Estazol | HMDB | | Stanazolol | HMDB, MeSH | | Tevabolin | HMDB | | Win 14833 | HMDB | | Winstroid | HMDB | | Winstrol depot | HMDB | | Winstrol V | HMDB | | Sanofi winthrop brand OF stanozolol | MeSH, HMDB | | Zambon brand OF stanozolol | MeSH, HMDB | | Methylstanazol | MeSH, HMDB | | Sanofi-synthelabo brand OF stanozolol | MeSH, HMDB |
|
|---|
| Chemical Formula | C21H32N2O |
|---|
| Average Molecular Weight | 328.4916 |
|---|
| Monoisotopic Molecular Weight | 328.251463656 |
|---|
| IUPAC Name | (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icosa-4,7-dien-17-ol |
|---|
| Traditional Name | stanozolol |
|---|
| CAS Registry Number | 10418-03-8 |
|---|
| SMILES | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NNC=C3C[C@]12C |
|---|
| InChI Identifier | InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1 |
|---|
| InChI Key | LKAJKIOFIWVMDJ-IYRCEVNGSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Estrane steroids |
|---|
| Direct Parent | Estrane steroids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Estrane-skeleton
- Hydroxysteroid
- 17-hydroxysteroid
- Azole
- Cyclic alcohol
- Pyrazole
- Tertiary alcohol
- Heteroaromatic compound
- Organoheterocyclic compound
- Azacycle
- Alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Status | Expected but not Quantified |
|---|
| Origin | |
|---|
| Biofunction | Not Available |
|---|
| Application | Not Available |
|---|
| Cellular locations | - Cell membrane
- Cytoplasm
- Membrane
|
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | |
|---|
